Israeli blood test could make lung-cancer detection faster, more accessible
Israeli scientists have developed a blood test that can detect lung cancer without DNA sequencing, potentially offering a faster and less expensive tool to complement existing imaging methods, Tel Aviv University announced on Monday.“Our goal is to make blood tests for cancer diagnosis more accessible, simpler and less expensive without compromising accuracy,” said Professor Yuval Ebenstein of the university’s School of Chemistry. “We have developed a new approach that does not require genetic sequencing but instead identifies the tumor’s chemical ‘fingerprint’ with light, using a technology that can be implemented in standard clinical laboratories.”Lung cancer is the leading cause of cancer-related deaths worldwide. Diagnosis currently relies heavily on CT scans, which can identify suspicious areas but also produce many findings that ultimately prove benign. Such findings can lead to unnecessary biopsies and surgeries.Liquid biopsies offer another approach, but many rely on DNA sequencing, which can be costly and require sophisticated…
Israeli scientists at Tel Aviv University have developed a new blood test for lung cancer that identifies a chemical "fingerprint" of cancer cells without requiring DNA sequencing. This technology aims to provide a faster, more accessible, and less expensive diagnostic tool to complement existing imaging methods like CT scans. Professor Yuval Ebenstein stated, "Our goal is to make blood tests for cancer diagnosis more accessible, simpler and less expensive without compromising accuracy."
- The test achieved 93.1% sensitivity and 90.3% specificity in distinguishing lung cancer patients from healthy individuals in a study of 103 participants with Stage 2-4 disease.
- It can potentially differentiate between adenocarcinoma and squamous cell carcinoma, two major forms of lung cancer.
- Preliminary findings suggest the technology could monitor patient responses to treatment, with changes in the DNA fingerprint correlating with imaging results.
- The test takes two to three days and costs approximately $60 per sample, making it potentially more accessible than some current liquid biopsy methods.
© All rights to the original article belong to the source. Din Online shows a headline, an excerpt and a link only. The objectivity rating is computed automatically and is an estimate only.
Discussion
No comments yet — be the first to comment.